Sinopharm
1099.HK
$2.54
Share price
-1.78%
Change (1 day)
-28.25%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $42.00 B
According to Sinopharm's latest financial reports the company's total liabilities are $42.00 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sinopharm - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $36.87 B | -0.33% |
| 2021-12-31 | $36.99 B | 9.05% |
| 2020-12-31 | $33.92 B | 22.84% |
| 2019-12-31 | $27.62 B | 13.41% |
| 2018-12-31 | $24.35 B | 19.36% |
| 2017-12-31 | $20.40 B | 25.19% |
| 2016-12-31 | $16.29 B | 7.19% |
| 2015-12-31 | $15.20 B | 1.94% |
| 2014-12-31 | $14.91 B | 17.48% |
| 2013-12-31 | $12.69 B | 36.07% |
| 2012-12-31 | $9.33 B | 24.15% |
| 2011-12-31 | $7.51 B | 82.08% |
| 2010-12-31 | $4.12 B | 51.39% |
| 2009-12-31 | $2.72 B | 46.14% |
| 2008-12-31 | $1.86 B | 16.63% |
| 2007-12-31 | $1.59 B | 38.75% |
| 2006-12-31 | $1.15 B |